Éric Béliveau, PhD
Program Manager
514-934-1934
ext. 76170
About Us
|
|
---|
Research
|
|
---|
Services
|
|
---|
The Infectious Diseases and Immunity in Global Health (IDIGH) Program unites expertise, resources and research strengths in infectious diseases, immunology and global health across three domains. It comprises 18 laboratory-based research groups at the Centre for Translational Biology, 16 groups with a focus on epidemiology and health outcomes research from the Centre for Outcomes Research and Evaluation, and 25 groups conducting clinical research associated with the Centre for Innovative Medicine.
The program is designed to act as a catalyst for innovative research and establish discovery pipelines in select diseases. It also aims to train the next generation of scientists in biomedical, clinical, and health outcomes research, and to facilitate capacity-building in resource-poor countries that are disproportionately affected by diseases of poverty (e.g., tuberculosis, leprosy, human immunodeficiency virus (HIV), and neglected tropical diseases). The synergistic interaction of methodological approaches ensures that research and training conducted within the program is interdisciplinary and multidisciplinary, with a strong translational focus.
Review our research highlights and publications in the 2023 RI-MUHC Annual Report.
We are proud to celebrate the scientific achievements of our researchers and trainees in publications, grant competitions, honors and awards, and appointments, as well as in the mainstream press.
The IDIGH Program organizes and supports numerous speakers, seminars, and symposia throughout the year.
Researchers in the IDIGH program are involved in a multitude of research initiatives, including:
The McGill Interdisciplinary Initiative in Infection and Immunity (MI4) brings together more than 250 researchers and leverages the power of translational research for the prevention, cure and elimination of major infectious and immune threats to human health.
The McGill International TB Centre is a world leader in the study of tuberculosis (TB), bringing together researchers in epidemiology, policy setting, and economic analyses, as well as experts in qualitative research and basic science in microbiology, host genetics and immune response.
The J.D. MacLean Centre for Tropical Diseases is a world-renowned centre of expertise, research, and training in clinical tropical medicine. It includes the Tropical Disease Clinic, the Pre-Travel Clinic and the National Reference Centre for Parasitology.
The PAHO/WHO Collaborating Centre for Research and Training in Parasite Epidemiology and Control disseminates knowledge and provides consultation to policy makers in parasite prevention and control, particularly related to epidemiological and biostatistical methods.
The Chronic Viral Illness Service (CVIS) provides patient-centered, multidisciplinary care to people living with chronic viral infections such as HIV and hepatitis C virus. It aims to advance care through practice-based research and to train health professionals.
The Centre of Excellence in Translational Immunology (CETI) brings together multidisciplinary research to understand the cellular and genetic underpinnings of immune-mediated diseases, and develop new diagnostic and therapeutic approaches to improve patient care.
The mission of the McGill University Health Centre Consortium for Rare Disease (MUHC-CRDR) is to facilitate patient-oriented, collaborative, trans-disciplinary healthcare and research in Rare Diseases across the lifespan.
GeoSentinel® is a worldwide network for the surveillance of travel-related morbidity. Aggregation of data across a network of 60 globally dispersed clinics on all continents allows linking of final diagnoses in migrating populations with similar geographic exposures.
Contact the IDIGH Program at the RI-MUHC. We are happy to hear from you!
The Research Institute of the McGill University Health Centre (RI-MUHC) is a world-renowned biomedical and healthcare research centre. The Institute, which is affiliated with the Faculty of Medicine of McGill University, is the research arm of the McGill University Health Centre (MUHC) – an academic health centre located in Montreal, Canada, that has a mandate to focus on complex care within its community. The RI-MUHC supports over 460 researchers and close to 1,200 research trainees devoted to a broad spectrum of fundamental, clinical and health outcomes research at the Glen and the Montreal General Hospital sites of the MUHC.